ArticleCell death & disease2026
Transcription-coupled nucleotide excision repair protects against genomic instability and cell death induced by the liver toxin methyleugenol.
Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Methyleugenol (ME) is a hepatotoxic phenylpropene naturally present in various herbs and spices. Following dietary exposure, ME undergoes metabolic activation in the liver, resulting in the formation of DNA adducts and liver damage. Although ME is a suspected human liver carcinogen, it is still unknown which DNA repair pathway removes the ME-induced DNA adducts. Here, we studied the relevance of nucleotide excision repair (NER) using various genetically engineered cell models. Our data show a crucial role for transcription-coupled (TC)-NER rather than global genome (GG)-NER, revealing that ME-induced DNA damage triggers detrimental transcription stress. Mechanistically, ME-derived DNA adducts stall RNA polymerase II (RNAPII), resulting in the chromatin release and cytoplasmic export of its active subunit RPB1, followed by proteasomal degradation to allow for repair and transcription recovery. Blocking of RNAPII by ME-derived DNA lesions promotes CSB immobilization and recruitment of CSA and UVSSA. The triggered canonical TC-NER pathway removes the ME-induced DNA lesions, preserves genome integrity and promotes cell survival. At high DNA adduct levels or in cells with deficient TC-NER, persistent transcription stress provokes genomic instability, induces apoptotic cell death and strongly reduces long-term cell survival. In contrast to that, GG-NER-compromised cells are not sensitized to ME-triggered cytotoxicity. Taken together, the canonical TC-NER pathway is crucial for the repair of DNA adducts induced by ME and likely also structurally related phenylpropenes. These findings are particularly important for Cockayne syndrome patients with defective TC-NER.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.